At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
THERMOCOOL SMARTTOUCH SF-5D Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation.
In Brief
A clinical study evaluating THERMOCOOL SMARTTOUCH SF-5D Catheter for Paroxysmal Atrial Fibrillation. Completed, enrolled 54 participants across 7 sites in 4 countries.
Detailed Summary
The QDOT-FAST study is a prospective, multi-center, non-randomized, interventional clinical study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation
CountriesAustria, Belgium, Czechia, Italy
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 2018
Enrollment StartApr 2018
Primary CompletionOct 2018
TodayJul 2026
First PostedMar 8, 2018
Enrollment StartApr 2, 2018
Primary CompletionOct 8, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.3 years ago
Interventions
THERMOCOOL SMARTTOUCH SF-5D Catheterdevice
radiofrequence ablation with THERMOCOOL SMARTTOUCH® SF-5D catheter used in combination with the nMARQ™ Multi-Channel RF Generator with TGA mode